Legend Biotech is recruiting a Cell Therapy Training Lead for the CAR-T European Manufacturing Hub in Ghent.
Legend Biotech is establishing two state of the art CAR-T manufacturing centers in Ghent (Belgium) together with our collaboration partner Janssen Pharmaceutica.
CAR-T (chimeric antigen receptor T cell therapy) is an innovative approach to treat blood cancer by harnessing the patients own immune system. The therapy is created from the patients own T cells which are engineered to eliminate cancer cells.
From the very beginning, we've been focused on the science. We came together as a team of experts, committed to quality, driven by excellence, and dedicated to experimentation. Though we faced many challenges, we remained fearless in our research and rigorous in our thinking, pushing ourselves to work harder. But what impacted us the most was the enormous burden patients’ bear and the difficulties they face, which drove us to think about what's next.
We believe it's time to accelerate and expand that transformation. At Legend Biotech, we are excited to bring clinical trials to patients in our pursuit of a cure. While we are focused on CAR-T in multiple myeloma, we firmly believe the prospects of cellular therapy stretch beyond just one disease or indication. The spark of hope is lit. At Legend Biotech, we're using that hope to ignite the future of CAR-T cell therapy.
Legend Biotech USA Inc. and Janssen Biotech, Inc., one of the pharmaceutical companies of Johnson & Johnson, have entered into a global, strategic collaboration to develop, manufacture, and commercialize a chimeric antigen receptor (CAR) T-cell therapy. This innovative strategic partnership is designed to combine the strengths and expertise of two companies to advance the promise of an immunotherapy CAR T platform and investigational treatment.
The Training Lead is responsible for developing the Training Strategy and overseeing training activities for the facility team members who support cGMP Clinical and Commercial Cell Therapy Manufacturing.
This individual will partner with other functions to develop the required capabilities to support personalized cell therapy production through safe and compliant operations according to cGMP requirements.
This individual will support organization build and ramp-up of clinical production and facility approval of a state of the art cell therapy facility for commercial launch and sustained production.
The role will require technical experience, effective communication, coordination and collaboration across relevant cross functional groups to enable robust production, testing and release of product to patients.
Ability to interact with all levels within the organization - Operations, Quality, HSE, Supply Chain, Warehouse, Training, QC, EM, Operations Technical Support, Facilities and Engineering, Validation.